INTRODUCTION
Malignant Small Round Cell Tumor (MSRCT) is defined as a highly undifferentiated neoplasm composed of monotonous population of small round cells with high nuclear to cytoplasmic ratio. Tumors that show good differentiation are generally easy to diagnose, but when a tumor is poorly differentiated, identification of the morphological features is difficult. Because of undifferentiated appearance of Malignant Small Round Cell Tumor, accurate diagnosis is difficult with routine H & E stain alone and so IHC is a valuable tool for all these cases. For treatment purposes and prognostic evaluation it is very important to differentiate whether the MSRCT is epithelial, mesenchymal, neuroendocrine, melanocytic, and hematopoietic. In more than 90% cases accurate diagnosis is made with the help of IHC along with routine H & E stain, but remaining cases require help of other ancillary technique like molecular or genetic study. [1] [2] [3] [4] For treatment purposes, it is crucial to determine whether an undifferentiated neoplasm is epithelial, mesenchymal, or hematopoietic. Treatment may include surgery, radiotherapy, chemotherapy, hormone therapy or a combination. For example, squamous cell carcinoma is treated with radiotherapy while adenocarcinomas require primary surgery since it is not as radiosensitive. For many types of sarcomas, combining surgery with radiation treatment has proven more effective than treatment with surgery alone. Chemotherapy is used to treat three types of sarcomas, all of which tend to occur in children under the age of 18; Osteosarcomas (bone sarcomas), Ewing's sarcomas (bone and soft-tissue sarcomas) and Rhabdomyosarcoma (muscle sarcomas) and radiation may be combined. Chemotherapy is now the main stay of therapy for most cases of lymphoma with local radiotherapy. Targeted therapy like anti-CD20 monoclonal antibody has been shown to be an effective therapy for CD-20 positive B-cell lymphoma. Malignant melanoma is treated by surgery/ palliation/ interferon. Extra gonadal germ cell tumors and neuroendocrine carcinomas are treated by chemotherapy. In general, the diagnosis of lymphoma for an undifferentiated tumor predicts a better clinical outcome compared with that of carcinoma.
5

METHODS
The study was carried out 
Interpretation of staining:
1. The positive control was examined for the presence of colored end product at the site of target antigen (DAB chromogen -brown end product). The presence of these colors was interpreted as a positive staining result, indicating proper performance of kit reagents) 2. Test specimen stained with the primary antibody was then examined. The absence of a colored end product was interpreted as a negative result. Main role of IHC is to recognize cell antigen and to identify and classify specific cell within cell population. After addition of Fluorochrome conjugate or enzyme to the antibody, visualization of Antigen-Antibody complex is made possible, which is seen under the microscope. There is use of extensive primary and secondary panel of Antibody for categorization of undifferentiated tumor.
The most common MSRCT in present study was NonHodgkin Lymphoma (18 cases). The tumor cells show Cytoplasmic and Membranous reactivity for CD45 (LCA). CD45 is a surface antigen expressed by virtually all haemato-lymphoid proliferations, and antibodies for this marker are specific. 15 In present study, 18 cases of NHL were found. Out of 18 cases, 9 cases were nodal and 9 cases were extra-nodal. There were 14 cases of B cell Lymphoma and 4 cases of T cell Lymphoma. In all suspected cases of NonHodgkin's lymphomas, a panel of antibodies including LCA (CD45), CD20 (Pan B markers), CD3 (Pan T markers), CD5, CD10 and CD30 are used. ALCL can only be diagnosed by immunohistochemistry because it is difficult to differentiate Anaplastic large cell lymphoma (ALCL) from diffuse large B cell lymphoma (DLBCL).
In suspected cases of ALCL, Epithelial membrane antigen (EMA) and CD30 are also used. Now a day's large number of cases of ALCL are diagnosed which in the past may have been misdiagnosed as Hodgkin's lymphoma or Diffuse Large B cell lymphoma. In present study 1 case of ALCL was diagnosed which was positive for CD30. In this study one case was diagnosed as Blastoid mantle cell lymphoma as it was reactive for CD 20, CD5 and negative for CD23. However in this case, Cyclin D1 and further cytogenetic study was advised for confirmation. One case of NK/T cell lymphoma nasal type was diagnosed which showed reactivity for LCA, CD 3, Vimentin and non-reactive for CD5, EMA, NSE and Chromogranin. There are prognostic and therapeutic differences between B cell and T cell Non-Hodgkin's Lymphomas which make immune-histological characterization very important and can be used for targeted therapy. Carcinoma, IHC study shows NSE (+), S 100 (+) while CK (-), LCA (-), Vimentin (-), EMA (-), so the final diagnosis was Neuroblastoma. Dendritic cell tumor CD68, LCA, CD3, CD23, Vimentin, S-100 CK, CD10, CD79a, CD56
Undifferentiated Nasopharyngeal carcinoma CK, NSE Vimentin, LCA, S-100
Embryonal Rhabdomyosarcoma Vimentin, S-100, Desmin, Myogenin NF, Synaptophysin, EMA, SMA, CD99, CEA
In present study, 3 cases of Synovial sarcoma found, all cases were immunopositive for CK, BCL 2, Vimentin, and Calretinin, while they were immunonegative for S-100, LCA, CD34, CD99, Desmin and HMB 45.
In present study, 2 cases of Ewing sarcoma was found, out of that one case was reported as MSRCT (In routine H & E stain) with two differential diagnosis: (1) Ewing sarcoma and (2) Alveolar Rhabdomyosarcoma, IHC study shows CD 99 (+), NSE (+), while Desmin (-), Myosin (-), EMA (-). Because of the negativity of the muscle marker Desmin and Myosin, the possibility of Alveolar RMS was ruled out, and diagnosis given was Ewing sarcoma.
In present study, 2 cases of Undifferentiated Neuroendocrine carcinoma was found, one case of Testicular mass was reported as MSRCT (In routine H & E stain) with three possibilities: (1) Alveolar Rhabdomyosarcoma, (2) Desmoplastic Small Round Cell Tumor (DSRCT) and (3) Ewing sarcoma/PNET. IHC study shows NSE (+), CD 56 (+), while Desmin (-), Myosin (-), CD99 (-), Calretinin (-), SMA (-), Synaptophysin (-), Chromogranin (-). In this case with the help of IHC, the final diagnosis was neuroendocrine carcinoma which was entirely different from previous morphological diagnosis, in this case NSE and CD56 were positive, while other neuroendocrine markers like Synaptophysin and Chromogranin were negative, which suggests that at least three markers for neuroendocrine lineage should be performed before rule out the possibility of neuroendocrine carcinoma. In present study, 2 cases of Desmoplastic Small Round Cell Tumor (DSRCT) was found, they were reported as MSRCT (In routine H & E stain) with two possibilities:
(1) Lymphoma and (2) DSRCT. IHC study shows Vimentin (+), EMA (+), Desmin (+), NSE (+) while LCA (-), CK (-). LCA was negative in this case so Lymphoma was ruled out; furthermore there were characteristic co-expression of mesenchymal and epithelial marker which confirms the diagnosis.
In present study, 1 case of Primitive Neuroectodermal Tumor (PNET) was found, which was reported as MSRCT with two differential diagnosis (1) DSRCT and (2) Primitive neuro-ectodermal Tumor and IHC study shows Vimentin (+), CD99 (+), NSE (+) while CK (-), S-100 (-), LCA (-), NF (-) so final diagnosis was PNET. In present study, 1 case of Amelanotic melanoma was reported, the case was reported as MSRCT (In routine H & E stain), IHC study shows HMB45 (+), S-100 (+), Vimentin (+), Desmin (-), LCA (-), CK (-). Therefore the case was reported as Amelanotic melanoma-small cell variant (Because of positivity of HMB45) though there was absence of melanin pigment in this case, it was reported as Melanoma, and this was possible with the use of IHC study.
In present study, 1 case of Anaplastic Dysgerminoma was found, IHC study shows Vimentin (+), PLAP (+), CD117 (+), while CK (-), LCA (-), S-100 (-), CD30 (-). In present study, 1 case of Osteosarcoma was found, IHC study shows Vimentin (+), Desmin (+), CD99 (+) while CK (-), LCA (-), S-100 (-), EMA (-), SMA (-).
In present study, 1 case of Wilm's tumor was found, IHC study shows Vimentin (+), EMA (+), NSE (+), while CK (-), S-100 (-), WT1 (-). Wilm's tumor although show WT1 positivity, but in our study it was WT1 negative.
In present study, 1 case of Dendritic cell tumor was found, IHC study shows CD68 (+), LCA (+), CD3 (+), CD23 (+), Vimentin (+), S-100 (+) while CK (-), CD10 (-), CD79a (-), CD56 (-).
In present study, 1 case of Undifferentiated Nasopharyngeal carcinoma was reported. This case is a Malignant Small round cell tumor (In routine H & E stain) with three possibilities: (1) Ewing sarcoma /PNET, (2) Undifferentiated Carcinoma and (3) Lymphoma. IHC study shows CK (+), Vimentin (+), NSE (+) while LCA (-), CD99 (-), S-100, Chromogranin (-). LCA was negative in this case so Lymphoma was ruled out furthermore CD99 was negative so Ewing sarcoma /PNET were ruled out, and final diagnosis was nasopharyngeal carcinoma. In present study, 1 case of Embryonal Rhabdomyosarcoma was found, IHC study shows Vimentin (+), Desmin (+), Myogenin (+), S-100 (+), while NF (-), Synaptophysin (-), EMA (-), SMA (-), CD99 (-), CEA (-), CD99 (-). Although differential diagnosis of Malignant Small Round Cell Tumor also includes Lymphoblastic Lymphoma, Retinoblastoma, Hepatoblastoma, Mesenchymal Chondrosarcoma but we did not get these cases in our study.
CONCLUSION
Malignant Small Round Cell Tumor are a group of neoplasm that are very well classified and diagnosed with the help of IHC, to ensure the appropriate and specific treatment. Because IHC can provide this with high precision, it must be performed with high standard. But in questionable cases in addition to IHC, molecular & genetic studies can use as a valuable tool.
